Innovations in HIV Therapeutics - Europe/North America Edition 2022

Invitation to Join Innovations in HIV Therapeutics - Europe/North America Edition

Our faculty members invite you to join the Innovations in HIV Therapeutics - Europe/North America Edition on 22 November 2022!

The COVID-19 pandemic drastically changed the delivery of HIV care, but there is more on the horizon.

New compounds with diverse modes of action and novel formulations have the potential to revolutionize HIV service delivery even more, as these may allow longer dosing schedules, increase adherence and improve cost-efficacy.

Therefore, there is a continuous need for medical education on new (long-acting) antiretroviral therapies (ART), novel formulations, and devices to provide the best care.

In contrast to existing educational activities that focus on approved or late-stage clinical data on ART, this program offers a platform entirely dedicated to HIV preclinical and early clinical development. This platform will consider regional differences in health care systems, with a focus on Europe and North America region.

Welcome

The Innovations in HIV Therapeutics - Europe/North America Edition took place as a virtual meeting on 22 November 2022.

As the pipeline of HIV drugs continues to evolve and novel formulations and devices are on the horizon, the HIV Therapeutics forum provides a scientific program that keeps HIV-treating clinicians, pharmacologists, and virologists updated on the latest data present in preclinical and early clinical development.

New formulations, novel compounds, and their modes of action will be presented, as well as their pharmacological properties, potential drug-drug interactions, and possible toxicities.

This forum will be provided in a virtual half-day program accounting for the unique regional differences present in the Europe/North America region.

General Information

Practical Information